Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.
Open Access
- 1 May 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 25 (5) , 585-589
- https://doi.org/10.1111/j.1365-2125.1988.tb03349.x
Abstract
1. The pharmacokinetics of isoniazid and acetylisoniazid in plasma and saliva were compared following administration of oral and intravenous doses (200 mg) to healthy volunteers and patients. 2. In the 22 subjects studied after oral administration and the six subjects studied after intravenous administration there was complete phenotypic agreement for both slow (t1/2 greater than 130 min) and fast (t1/2 less than 130 min) acetylators using either saliva or plasma. 3. Acetylator phenotyping based on the t1/2 of INH determined using saliva collected at 2, 3, 4, 5 and 6 h after a 200 mg oral dose appears to be as reliable as that based on plasma. 4. Salivary isoniazid concentrations may provide a non-invasive alternative to plasma concentrations.This publication has 7 references indexed in Scilit:
- Stability of Isoniazid and Acetylisoniazid in SalivaTherapeutic Drug Monitoring, 1988
- A simple method for determining acetylator phenotype using isoniazid.British Journal of Clinical Pharmacology, 1986
- High-performance Liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- A method to prevent the loss of isoniazid and acetylisoniazid in human plasma.British Journal of Clinical Pharmacology, 1983
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979
- Plasma and salivary concentrations of isoniazid in man: Preliminary findings in two slow acetylator subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Pharmacokinetics of tolbutamide: Prediction by concentration in salivaClinical Pharmacology & Therapeutics, 1974